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ABSTRACT
The Role of Receptors for Advanced Glycation End-Products (RAGE)
and Ceramide in Cardiovascular Disease
Michael Bruce Nelson
Department of Physiology and Developmental Biology, BYU
Master of Science
Type 2 diabetes and cigarette smoke exposure are associated with an increased risk of
cardiovascular complications. The role of advanced glycation end-products (AGEs) is already
well-established in numerous comorbidities including cardiomyopathy. Given the role of AGEs
and their receptor, RAGE, in activating inflammatory pathways, we sought to determine whether
ceramides could be a mediator of RAGE-induced altered heart mitochondrial function. Using an
in vitro model, we treated H9C2 cardiomyocytes with carboxy-methyl lysine-BSA, followed by
mitochondrial respiration assessment. We found that mitochondrial respiration was significantly
impaired in AGE-treated cells, but not when co-treated with myriocin, an inhibitor of de novo
ceramide biosynthesis. Moreover, we exposed WT and RAGE KO mice to side-stream cigarette
smoke and found reduced mitochondrial respiration in the left ventricle myocardium from WT
mice, but the RAGE KO mice were protected from this effect. Finally, conditional overexpression of RAGE in the lungs of mice also elicited a robust increase in left ventricular
ceramides. Altogether, these findings suggest a RAGE-ceramide axis as an important contributor
to cardiomyopathy.
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CHAPTER 1: Introduction
According to the Centers for Disease Control and Prevention, cardiovascular disease is
currently the number-one leading cause of death in the United States (CDC; 2010). In 2010, just
under 600,000 reported deaths were attributed to heart disease, with an additional 216,000
stemming from chronic lower respiratory disease and diabetic complications (CDC, 2010).
Although there are genetic aspects to cardiovascular disease, it’s well-established that many of
the risk factors stem from lifestyle components including diet and body mass index (Jones,
2010). Chief among those risk factors are whether or not the individual is diabetic (Lorber, 2014)
and whether or not they smoke on a regular basis (Messner & Bernhard, 2014). Indeed, many of
the additional 216,000 deaths may have carried cardiovascular comorbidities.
These risk factors play a role in the lives of many Americans. They often reduce the
quality of life, increase the burden of medical costs, and significantly shorten life-span (SicrasMainar, Navarro-Artieda, & Ibanez-Nolla, 2013). Current estimates suggest that over 26 million
Americans are diabetic as defined by their HbA1C level, and its predicted that approximately
half of Americans will be diagnosed by the year 2020 (Hawks, 2013). Although the prevalence
of cigarette smoke usage has declined over the last 50 years, one recent report also suggested that
approximately one-fifth of working adults still smoke (Burns, 2014). Although diet, exercise, and
healthy lifestyles are undoubtedly the best preventative measures, a greater understanding of the
mechanistic pathology could provide novel methods to ameliorate and treat cardiovascular
complications as individuals work to treat the underlying causes of their conditions. Where we
currently stand, two players that merit further investigation for the role they play in
cardiovascular disease are the receptor of advanced glycation end-products (RAGE) and the
sphingolipid ceramide.
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Receptor of Advanced Glycation End Products (RAGE)
RAGE is a pattern-recognition receptor of the immunoglobulin family (Robinson,
Johnson, Bennion, & Reynolds, 2012). Under normal physiological circumstances, membranebound RAGE (mRAGE) serves a protective role by generating non-specific inflammatory
responses to a host of heterogeneous compounds, but can introduce complications with sustained
activation and chronic inflammation (Tobon-Velasco, Cuevas, & Torres-Ramos, 2014). It
contains a variable extracellular V-region-like immunoglobulin domain, two constant C-regionlike domains, a single-pass transmembrane domain, and a cytosolic domain that is responsible
for mediating signal transduction (Robinson, Stogsdill, Lewis, Wood, & Reynolds, 2012). Other
forms of RAGE, however, including soluble RAGE (sRAGE) and endogenous secretory RAGE
(esRAGE), are also found in the body, but are incapable of generating inflammatory responses
(Huang, Que, & Shen, 2014).
The receptor is highly expressed in the lung alveoli (Reynolds et al., 2008), and much of
our lab’s research on RAGE has focused on its role in the context of lung exposure to cigarette
smoke, and to a lesser degree, environmentally available diesel particulate matter (Reynolds,
Wasley, & Allison, 2011). Because of its expression profile, it is thought to play a key role
during embryonic lung development and to contribute significantly to the progression of COPD
(Stogsdill et al., 2013; Winden et al., 2013). Numerous studies, however, have also affirmed that
RAGE is expressed in peripheral tissues including vasculature and cardiac tissue (Yu et al.,
2013). In many of these other tissues, RAGE may be involved in promoting macrovascular and
microvascular complications (Chawla et al., 2014) and contribute to the onset of cardiomyopathy
(Bodiga, Eda, & Bodiga, 2014). Indeed, the contribution of RAGE to cardiovascular disease has
been well-documented (Yan, Ramasamy, & Schmidt, 2009).
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RAGE binds to a host of ligands including S100/calgranulin polypeptides, HMGB1, and
advanced glycation end products (AGEs) derived through the non-enzymatic combination of
amino groups and reducing sugars (Ibrahim, Armour, Phipps, & Sukkar, 2013; Xue et al., 2014).
Ligands of RAGE, however, are also found abundantly in the environment. Dietary AGEs are
present in the foods we ingest, and they can be readily absorbed from the gut (Poulsen et al.,
2013). They also form a major constituent of cigarette smoke, and are generated through
Malliard chemical reactions involving smoke components and plasma proteins (Vlassara &
Palace, 2002). Indeed, previous studies have revealed that serum levels of AGEs are higher in
smokers compared to non-smokers (Cerami et al., 1997). Finally, AGEs can also be produced
endogenously within our bodies. Chronic hyperglycemia can generate oxidative stress and
activate several mechanisms leading to increased production of advanced glycation end-products
from methylglyoxal derivatives (Gaens, Stehouwer, & Schalkwijk, 2013). Chief among those
AGEs are proteins with N(ε)-carboxy-methyl-lysine (CML) and N(ε)-carboxy-ethyl-lysine
adducts (Schmitt, Linder, Standker, Hammes, & Preissner, 2008; Xue et al., 2011). As these
AGEs accumulate, they can interact with RAGE in vasculature, lung, and heart where they
activate signaling cascades that increase expression of pro-inflammatory cytokines that mediate
inflammatory responses (Brett et al., 1993). Of note, interaction between CML and RAGE is
thought to promote signaling through NF-kB to increase expression of cytokines including IL1β, IL-6, and TNFα (Tobon-Velasco et al., 2014). These cytokines may, in turn, regulate
endogenous production of sphingolipids.
Ceramide
For years, the role of sphingolipids was unknown. In fact, the very word “sphingolipid” is
rooted in reference to the mythological sphinx of Greek tradition (Merrill et al., 1997).
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Nowadays, however, sphingolipids are known to be a necessary component of cell membranes
(Ohta et al., 2009) and to modulate numerous processes including inflammation, apoptosis and
autophagy (Schilling et al., 2013). As such, they play a crucial role in heart health and the
development of cardiovascular disease (de Faria Poloni, Chapola, Feltes, & Bonatto, 2014).
Ceramides fall into this family of lipid, and they can be generated through one of several
pathways (Kogot-Levin & Saada, 2014). One such pathway is the de novo pathway in which
palmitoyl-CoA is converted to ceramide through several enzymes including serine
palmitoyltransferase, 3-ketosphingosine reductase, ceramide synthase and ceramide desaturase
(Brice & Cowart, 2011). Another method, known as the recycling pathway, involves the
cleavage of sphingomyelin by acid- and neutral-sphingomyelinase enzymes to generate ceramide
(Claus, Dorer, Bunck, & Deigner, 2009). Many of these enzymes involved in ceramide
production can be targeted pharmacologically; however, SPT2 is often the main target and
widely recognized as the rate-limiting enzyme of ceramide biosynthesis (Batheja, Uhlinger,
Carton, Ho, & D'Andrea, 2003). Despite the important role ceramide plays, it’s increasingly
believed that excessive accumulation of this particular sphingolipid in heart and blood vessels
may be an important factor in the etiology of various disease states.
Hyperlipidemia and the accumulation of lipotoxic metabolites in heart may increase the
risk of cardiovascular disease (Kang, Kim, Lee, & Park, 2013). Ceramides have been shown to
interfere with signaling pathways involved with various metabolic and physiological processes.
For example, it has been shown to induce insulin resistance in skeletal muscle by interfering with
insulin signaling pathways (Russo, Ross, & Cowart, 2013), promote hypertension by blocking
phosphorylation of eNOS in vascular tissue (Zhang et al., 2012), and even exacerbate
emphysema-like symptoms in lung (Petrache et al., 2005). Other studies have asserted that
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ceramide can induce cardiomyocyte death by altering mitochondrial metabolism (Parra et al.,
2013). One plausible explanation for the latter observation is that ceramide has been shown to
stimulate mitochondrial fission (Smith et al., 2013). This paradigm of ceramide-mediated
mitochondrial fission in heart, however, has yet to be fully investigated. Because activation of
inflammatory signaling pathways has been shown to upregulate ceramide biosynthesis (Bikman,
2012), it’s possible that inflammation mediated by RAGE may play a role in the de novo
biosynthesis of ceramide by lung and heart.
Summary of Research
Previous research conducted in our lab has reinforced the notion of RAGE and ceramide
as key players in cardiovascular disease. Our lab has previously demonstrated that A549 cells
synthesize and actively secrete ceramides in response to treatment with growth media infused
with cigarette smoke extract (CSE) (Thatcher et al., 2014). Following this observation, we
hypothesized that, in living organisms, the lungs can actively secrete ceramides into the blood in
response to cigarette smoke. Following secretion, these sphingolipids can then travel
systemically and accumulate in peripheral tissues where they disturb regular metabolic
processes. Specifically, we have demonstrated that cigarette smoke exposure increases ceramide
accumulation in both skeletal muscle and heart (Thatcher et al., 2014; Tippetts et al., 2014).
Furthermore, we’ve shown that ceramides stimulate mitochondrial fission and reduce
mitochondrial respiration by upregulating dynamin related protein 1 (Smith et al., 2013). Despite
these observations, however, we have yet to offer a mechanism accounting for the increase in
ceramides.
Interestingly, RAGE shares some similarities with another receptor that is known to
increase ceramide biosynthesis. Several studies have shown that the interaction of both palmitic
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acid and LPS with Toll-like Receptor 4 (TLR4) in cellular macrophages results in increased
production of ceramide (Schilling et al., 2013). RAGE and TLR4 both share similar ligands and
activate similar signaling pathways (Ullah et al., 2014; Veloso et al., 2011); therefore, RAGE
may exacerbate TLR4-mediated effects by inciting parallel signaling pathways in both cardiac
and lung tissue. Both RAGE and TLR4 signal through the canonical NF-kB pathway to increase
expression of inflammatory cytokines (Ibrahim et al., 2013; Reynolds, Kasteler, Schmitt, &
Hoidal, 2011). These inflammatory cytokines, in turn, may act to activate or increase expression
of enzymes involved in either the de novo pathway or recycling pathway of ceramide
biosynthesis (Medler et al., 2008). Since RAGE is expressed in heart and lung, there is a high
likelihood that activation of RAGE by advanced glycation end-products promotes
cardiomyopathy by enhancing cardiac ceramide accumulation and reducing the metabolic
efficacy of cardiomyocytes.
To our knowledge, the study outlined in the following chapter is the first to test the
possibility of a RAGE-ceramide axis in both cardiac and lung tissue. This research helps to
identify mechanisms of increased cardiac ceramide accumulation and to what extent ceramide
mediates the effects of RAGE in diabetic and smoke-induced cardiovascular disease.
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Abstract
Cigarette smoke exposure is associated with an increased risk of cardiovascular
complications. The role of advanced glycation end-products (AGEs) is already well established
in numerous comorbidities including cardiomyopathy. Given the role of AGEs and their
receptor, RAGE, in activating inflammatory pathways, we sought to determine whether
ceramides could be a mediator of RAGE-induced altered heart mitochondrial function. Using an
in vitro model, we treated H9C2 cardiomyocytes with the AGE carboxy-methyl lysine prior to
mitochondrial respiration assessment. We discovered that mitochondrial respiration was
significantly impaired in AGE-treated cells, but not when co-treated with myriocin, an inhibitor
of de novo ceramide biosynthesis. Moreover, we exposed WT and RAGE KO mice to
secondhand cigarette smoke and found reduced mitochondrial respiration in the left ventricle
myocardium from WT mice, but the RAGE KO mice were protected from this effect. Finally,
conditional over-expression of RAGE in the lungs of transgenic mice elicited a robust increase in
left ventricular ceramides in the absence of smoke exposure. Altogether, these findings suggest a
RAGE-ceramide axis as an important contributor to AGE-mediated disrupted cardiomyocyte
mitochondrial function.
Introduction
Receptors for advanced glycation end-products (RAGE) are important mediators of
numerous chronic complications. Many of these conditions, including peripheral neuropathy
(Bekircan-Kurt, Uceyler, & Sommer, 2014), retinopathy (Abu El-Asrar et al., 2014; Chen,
Curtis, & Stitt, 2013), nephropathy (Zhou, Wang, Zhu, & Hao, 2012), and cardiomyopathy
(Bodiga, Eda, & Bodiga, 2014; Ma et al., 2009), reduce quality of life (Rodriguez-Pascual et al.,
2011) and often involve macrovascular and microvascular complications (Chawla et al., 2014).
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RAGE was originally characterized for its ability to bind advanced glycation end-products
(AGEs) and for its role as a prominent feed-forward receptor involved in inflammation
(Reynolds et al., 2008). AGEs are derived via the non-enzymatic combination of amino groups
and reducing sugars (Nicholl & Bucala, 1998) and hyperglycemia-mediated induction of protein
glycosylation is implicated in the production of systemic AGEs (Hodgson et al., 2014; Xue et al.,
2014). However, independent of blood glucose, cigarette smoke exposure increases AGE
formation through Malliard chemical reactions involving smoke components and plasma proteins
(Nicholl et al., 1998). Whether through chronic hyperglycemia or secondhand cigarette smoke
exposure, cellular responses provide abundant AGEs for RAGE signaling that causes enhanced
expression of pro-inflammatory cytokines and deleterious inflammatory responses (Manigrasso,
Juranek, Ramasamy, & Schmidt, 2014). Two AGEs often found in increased abundance with
diabetics and smokers are N(ε)-carboxy-methyl-lysine (CML) (Schmitt, Linder, Standker,
Hammes, & Preissner, 2008) and N(ε)-carboxy-ethyl-lysine (Xue et al., 2011).
In addition to RAGE, sphingolipids are another factor increasingly recognized to play a
role in the progression of inflammatory disorders (Bikman, 2012; Maceyka & Spiegel, 2014).
Ceramides, in particular, are a subset of sphingolipid that have been linked to cardiometabolic
disruption (Tippetts et al., 2014), altered mitochondrial dynamics and function (Bikman &
Summers, 2011; Smith et al., 2013; Summers, 2006), increasing atheroma development
(Bismuth, Lin, Yao, & Chen, 2008), and mediating insulin resistance (Thatcher et al., 2014). We
have previously shown that ceramides are actively synthesized in the lung with cigarette smoke
exposure (Tippetts et al., 2014).
Since activation of inflammatory signaling pathways has been shown to up-regulate
ceramide biosynthesis (Bikman, 2012), it is plausible that RAGE-mediated inflammation can
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stimulate the synthesis and elaboration of ceramides. RAGE functions as other pattern
recognition receptors, including Toll-like receptor 4, which increases ceramide biosynthesis upon
activation (Holland et al., 2011). This paradigm involving a connection between RAGE and
ceramide, however, has yet to be fully investigated. Based on this intersection, we hypothesized
that RAGE-AGE signaling would increase cardiomyocyte ceramide accrual, thereby increasing
ceramide-mediated cardiomyocyte mitochondrial dysfunction.
Materials and Methods
Cell Culture
Immortalized rat H9C2 cardiac myocytes were obtained from America Type Cell Culture
(ATCC; Manassas, VA) and used at passages 9-12. CML-BSA was purchased from MBL
International (Woburn, MA), and the myriocin was obtained from Sigma-Aldrich (St. Louis,
MO). The cells were split into 6-well plates and grown to confluency. Myriocin-treated cells
were pretreated for 1 hour with 1μL of 10 mM myriocin. Cells were subsequently co-treated with
either 30 μL CML-BSA/mL growth media or normal growth media for 24 hours. All subsequent
analysis took place after the exposure period.
Mice
Wild type (WT) C57BL/6 mice are in house and were obtained from Jackson
Laboratories (Bar Harbor, ME). RAGE knock out (KO) mice lacking membrane and soluble
RAGE were generated on a C57BL/6 background. Conditional RAGE transgenic mice were also
generated that overexpress RAGE in alveolar epithelium when fed doxycycline (dox) (Reynolds,
Stogsdill, Stogsdill, & Heimann, 2011; J. A. Stogsdill et al., 2012). Dox incorporation into
murine diets caused the up-regulation of RAGE in the lungs of transgenic mice from postnatal
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day 20 until sacrifice date at postnatal day 110 (M. P. Stogsdill et al., 2013). The mice were kept
on normal light/dark cycles and had free access to food and water. Housing and treatment of all
mice were in accord with approved IACUC protocols at Brigham Young University.
Smoke Exposure
For one study, WT and RAGE KO mice were randomly assigned to control- and smokeexposure groups and acutely treated using an in-house nose-only smoke exposure system
(InExpose System, Scireq, Canada). Over the course of 1 week, the mice were restrained daily
and connected to an exposure tower for 10 minutes where they were nasally exposed to
secondhand cigarette smoke from 2 cigarettes. Computer-generated puffs resulted in 10 seconds
of secondhand exposure followed by 50 seconds of fresh air. After exposure, the mice were then
allowed to rest for 10 minutes before repeating the process two additional times until they had
been exposed to a total of 6 cigarettes per day. The smoke challenge chosen in the study was
associated with a good tolerance of mice to the smoke sessions, and an acceptable level of
particulate density concentration according to literature (Rinaldi et al., 2012; Wood et al., 2014).
Control animals were similarly handled and restrained but kept under a smoke-free environment.
In a second chronic exposure study, WT mice were similarly assigned to control- and smokeexposure groups and exposed to secondhand smoke. The procedure, however, included exposure
to 4 cigarettes per day for 8 weeks. Studies were performed in accordance with principles
outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Immunohistochemistry
Heart tissue from control- and cigarette smoke-exposed mice was fixed in 4%
paraformaldehyde, processed, embedded in paraffin wax, sectioned, and stained according to
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standard immunohistochemical procedures (Reynolds, Mucenski, Le Cras, Nichols, & Whitsett,
2004; Robinson, Johnson, Bennion, & Reynolds, 2012). The ceramide primary antibody used for
immunohistochemical detection was obtained from Sigma Aldrich (C8104-50TST, 1:500).
Development in 3,3-diaminobenzidone (DAB) revealed enhanced brown chromogen in tissues
positive for ceramide expression.
Mass Spectrometry
In isolating lipids, pellets were suspended in ice-cold chloroform/methanol (1:2),
incubated for 15 minutes on ice, then briefly vortexed. Aqueous and organic phases were
separated by addition of ice-cold water and chloroform. The organic phase was collected in a
fresh vial and dried via vacuum centrifugation (Eppendorf Concentrator Plus). Lipids were then
characterized and quantified using shotgun lipidomics on a Thermo ScientificLTQ Orbitrap XL
mass spectrometer, as previously described (Hansen et al., 2014).
Mitochondrial Respiration
Oxygen consumption from H9C2 cardiomyocytes and cardiac muscle obtained from mice
was determined using an O2K oxygraph (Oroboros Instruments). Cells (digitonin 1mg/ml) and
tissue (saponin 50 µg/ml) were then permeabilized. Following permeabilization, samples were
transferred to respiration chambers. Respiration was determined using a substrate-uncouplerinhibitor titration protocol. Electron flow through complex 1 was assessed by supporting the
system with glutamate (G, 10 mM) and malate (M, 2 mM). Following stabilization, ADP was
added to determine oxidative phosphorylation capacity (P, 2.5 mM). Succinate (S, 10 mM) was
then added to assess complex 1 + 2 electron flow. To determine full electron transport system
capacity, the chemical uncoupler FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone,
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0.05 μM) was added (E). In order to assess complex 2 electron flow, complex 1 was then
inhibited by including rotenone (Rot, 0.5 μM).
Real Time PCR
RNA from cells was isolated using Trizol (Invitrogen, Grand Island, NY) and quantified
via optical density measurement. Reverse transcription of RNA was performed using Superscript
III First-Strand Synthesis System in order to obtain cDNA for PCR. Primers for serine
palmitoyltransferase 1 and 2 (SPT1, SPT2) and ceramide synthase 2 (CERS2) were obtained and
diluted according to the manufacturer’s protocol. Bio Rad iQ SYBR Green Supermix was used
to perform Real Time PCR, along with previous cDNA, primers, and water. Values were
assessed using the ΔΔCT method and comparisons were made with amplified actin. Control
wells lacking template or RT were included to identify primer-dimer products and to exclude
possible contaminants.
Immunoblotting
Total protein from H9C2 cardiac myocytes and heart tissue was obtained after
homogenization with RIPA buffer supplemented with protease inhibitors (Fisher Scientific,
Waltham, MA). Protein was then quantified using a BCA Protein Assay Kit (Fisher Scientific)
and 20 μg of the resulting lysate was blotted using a mouse polyclonal antibody (RnDSystems,
Pittsburg, PA, #AF1179) against RAGE (1:1000) as already outlined (Reynolds et al., 2010).
Western blots were visualized and quantified using a LI-COR C-DiGit Blot Scanner (LI-Cor
Biosciences). Quantification of RAGE was performed by densitometry and normalization with
actin provided comparisons between samples.
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Statistics
In vitro data presented are representative of experiments performed in triplicate and
animal experiments involved at least 4 samples per group. Data are presented as the mean ±
SEM. Data were compared by ANOVA with Tukey’s post-hoc analysis (Graphpad Prism; La
Jolla, CA). Significance was set at p < 0.05.
Results
AGEs Reduced Cardiomyocyte Mitochondrial Function In A Ceramide-Dependent Manner
CML is one of the most physiologically relevant AGEs in a diabetic context. To assess
the effects of AGEs on cardiomyocytes, we treated H9C2s with growth media containing CMLBSA, with and without myriocin, an inhibitor of serine palmitoyltransferase (SPT), the rate
limiting enzyme in de novo ceramide biosynthesis. Compared to control cells, gene expression
levels of SPT1, SPT2, and CerS2 were significantly elevated in CML-treated cells (Figure 2.1A).
Similarly, compared to control conditions, cells exposed to CML-BSA showed a robust increase
in ceramide production by mass spectrometry, but not when pretreated with myriocin
(CML+MYR; Figure 2.1B). The increase in SPT and ceramides plausibly implicate RAGE as a
factor contributing to de novo ceramide biosynthesis.
In order to determine the effect of RAGE-mediated inflammation on heart cell function,
we similarly exposed H9C2 cardiomyocytes to the same conditions described above and assessed
mitochondrial respiration using a substrate-uncoupler-inhibitor titration protocol (see materials
and methods). A significant reduction in respiration was elicited in cells treated with CML-BSA
upon addition of glutamate and malate (leak state, GML) (Figure 2.2A). Pre-treatment with
myriocin, however, abolished the effects of CML-BSA and restored respiration to control levels.
Similar results were also found upon stimulation of complex 1-mediated oxidative
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phosphorylation with ADP addition (GMP). Addition of succinate to introduce complex IImediated respiration (GMSP) revealed a slight departure from the trend; whereas CML-treated
cells experienced a comparable increase in respiration as control cells, CML treatment appeared
to blunt the normal response to succinate addition. We further observed reduced complex II
function when analyzing the Complex II Control Factor (GMSP less GMP; Figure 2.2B). Similar
to succinate addition, the addition of FCCP (respiration uncoupler) (GMSE) failed to increase
respiration with CML treatment to a level seen with control or myriocin treatment. Altogether,
these findings suggest that respiration in cardiomyocytes is impaired by RAGE signaling and is
mediated through increased ceramide accrual.
RAGE Signaling Contributed To Cigarette Smoke-Induced Ceramide Accrual In Cardiomyocytes
Because AGEs and smoke impact ceramide levels in vitro, we next assessed whether
similar effects occurred in vivo. Specifically, as RAGE expression is known to be elevated with
inflammation and exposure to cigarette smoke (Ramasamy & Schmidt, 2012; Wood et al., 2014),
we sought to ascertain the expression profile of RAGE in cardiac tissue under both control
conditions and following smoke exposure. To establish its expression in heart, WT mice were
restrained and exposed to either room air or secondhand cigarette smoke for one or 8 weeks.
Following the treatment, we assessed RAGE protein expression in left ventricle myocardium.
Compared to control animals, RAGE expression was significantly elevated in animals after one
week (not shown) or eight weeks of secondhand cigarette smoke exposure (Figure 2.3). We next
analyzed ceramide levels by mass spectrometry in order to assess whether ceramides are also
elevated in cardiomyocytes following secondhand smoke exposure. WT mice exposed to acute
cigarette smoke showed a significant increase in ceramides (Figure 2.4A); however, this effect
was diminished in RAGE KO mice after one week of exposure. In order to qualitatively
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visualize these differences, we also performed immunohistochemistry on heart samples for
ceramides. WT mice exposed to secondhand cigarette smoke expressed pronounced DABmediated staining for ceramides in heart tissue (Figure 2.4B, arrow), but ceramides were
qualitatively diminished in exposed RAGE KO mice (Figure 2.4B).
RAGE Signaling Was Necessary For Cigarette Smoke-Mediated Reductions In Myocardial
Mitochondrial Respiration
Following exposure to secondhand cigarette smoke, left ventricular myocardium from
WT and RAGE KO mice was permeabilized and assessed for mitochondrial respiration. WT
mice showed altered mitochondrial respiration in response to acute cigarette smoke exposure
(Figure 2.5A). However, RAGE deletion was protective against secondhand smoke-induced
respiration defects (Figure 2.5A). As with cells, we observed reduced complex II function when
analyzing the Complex II Control Factor (GMSP less GMP; Figure 2.5B).
Conditional Pulmonary Up-Regulation Of RAGE Increased Biosynthesis Of Cardiomyocyte
Ceramides
The experiments outlined in Figures 3-5 considered the biology of RAGE and ceramide
in cardiomyocytes following controlled pulmonary exposure to secondhand smoke. To further
assess the role of RAGE in promoting cardiac accumulation of ceramide, studies were designed
in the absence of smoke that compare control mice and conditional transgenic mice that
genetically over-express RAGE in the peripheral lung. Up-regulation of RAGE in these mouse
models has been validated by both immunoblotting and qPCR (J. A. Stogsdill et al., 2012; M. P.
Stogsdill et al., 2013). Lipids were purified from heart tissue obtained from RAGE transgenic
mice following 90 days of RAGE up-regulation and age-matched non-transgenic controls prior
to subjection to mass spectrometry analysis. Compared to the control mice, hearts from
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transgenic mice showed a significant increase in ceramides (Figure 2.6), further supporting the
notion that RAGE is a sufficient mediator of de novo ceramide biosynthesis in cardiac tissue.
Discussion
This study assessed the effects of RAGE stimulation on cardiomyocyte ceramide accrual
and mitochondrial function. Because AGEs are established factors in the progression of
cardiovascular complications (Ma et al., 2009; Nozynski et al., 2012), our goal was to assess
whether RAGE signaling leads to mitochondrial disruption in heart tissue and whether ceramide
is an obligate mediator of these effects. Our results demonstrated that cardiomyocytes respond
to AGE treatment with a robust increase in ceramide accrual. This increase may be due, at least
in part, to increased expression of the initial and rate-limiting enzymes of ceramide biosynthesis
(i.e., SPT), as well as CerS2. To our knowledge, our results are the first to establish a RAGEceramide axis within heart cells and tissue.
Under normal physiological circumstances, RAGE serves a protective role by generating
a non-specific inflammatory response to a host of heterogeneous compounds, but this process
can become pathological with sustained activation and chronic inflammation (Nedic, Rattan,
Grune, & Trougakos, 2013). Although the scope of our paper is limited to the effects of RAGE
and ceramides on cardiomyocyte mitochondrial function, both are implicated in a host of diabetic
and smoke-induced cardiovascular complications. However, AGEs inhaled by smokers may be
chemically and functionally different when compared to de novo AGE synthesis in uncontrolled
diabetics. Ma et al. (Ma et al., 2009) revealed that AGE-RAGE ablation prevents diabetesinduced altered cardiovascular function, including cardiomyopathy. Moreover, Park et al. (Park,
Rosebury, Kindt, Kowala, & Panek, 2008) found that ceramide inhibition through SPT ablation
is protective against dilated diabetes-induced cardiomyopathy. Thus, in light of our results of
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increased ceramides with RAGE activation in heart tissue, future work will seek to determine
whether ceramides are necessary for altered heart function orchestrated by RAGE signaling.
Importantly, mitochondrial dysfunction may play a critical role in the pathogenesis of
cardiomyopathy (Duncan, 2011). This is relevant given our previous findings that ceramides
directly disrupt mitochondrial physiology, reducing respiration and increasing oxidative stress
(Tippetts et al., 2014), through a mitochondrial fission-dependent process (Smith et al., 2013).
We previously found that ceramide accrual exhibited a widespread inhibition of mitochondrial
respiration, but the effect appeared more selective to inhibiting complex II-mediated respiration.
We note similar findings in this report—CML-treated cells did not experience the succinateinduced respiration increase evidenced in both the control- and myriocin-treated cells. Our
demonstration that AGEs induce ceramide-dependent impairment in mitochondrial oxygen flux
may explain, at least in part, why diabetic hearts are characterized by contractile impairment
from anomalous energy metabolism.
Our rationale for targeting RAGE as an activator of ceramide accrual in heart stems from
two observations: 1) as noted earlier, RAGE mediates cardiovascular complications (Ma et al.,
2009); and 2) RAGE shares common signaling intermediates in pathways known to activate
ceramide biosynthesis, namely Toll-like receptor 4 (TLR4). We reported in 2011 that TLR4 is
required for lipid- and endotoxin-induced ceramide biosynthesis (Holland et al., 2011).
Interestingly, not only do TLR4 and RAGE share common downstream signaling (e.g., IRAK)
(Sakaguchi et al., 2011), but also common ligand activators (e.g., HMGB1) (Ding et al., 2013;
Sims, Rowe, Rietdijk, Herbst, & Coyle, 2010). Our use of cigarette smoke exposure as an
intervention to stimulate RAGE expression is based on our earlier reports of smoke exposure
eliciting a robust increase in lung RAGE expression (Reynolds, Kasteler, Schmitt, & Hoidal,
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2011; Robinson, Stogsdill, Lewis, Wood, & Reynolds, 2012), which is a necessary event in
transducing inflammation. However, the increase in heart RAGE expression is novel and
conveys the possible importance of RAGE modulation in heart complications. To our
knowledge, while Denis et al. (Denis et al., 2002) were the first to find a ceramide-RAGE
connection when they noted a roughly twofold increase in ceramides in cultured bovine pericytes
with AGE exposure, our data may be the first to reveal this phenomenon in whole tissue.
Moreover, our evidence of RAGE-mediated increased ceramides in animals exposed to cigarette
smoke and in the lungs of RAGE TG mice speaks to the influence of lung RAGE signaling on
heart ceramide accrual. Despite the clear implication of RAGE in ceramide accrual, important
questions remain such as to what extent RAGE signaling intermediates participate in ceramide
biosynthesis and mitochondrial function, and how pulmonary RAGE up-regulation impacts
ceramide accrual in heart tissue.
Given the considerable cardiovascular burden inherent to cigarette smoke exposure
(Talukder et al., 2011; Tonstad & Svendsen, 2005), our results provide a possible mechanism
whereby smoke exposure leads to cardiovascular complications. Ceramide has been shown to
mediate cardiomyopathy (Park, Hu, et al., 2008), atherosclerosis (Bismuth et al., 2008), and
inhibit NO-induced vasodilation (Zhang et al., 2012). Thus, our results may have broad
implications for cardiovascular therapies.
In conclusion, our results demonstrate that RAGE signaling reduces heart mitochondrial
respiration in a ceramide-dependent manner. Considering the dependence of myocardium on
normal mitochondrial function, these results provide evidence for the utility of anti-ceramide
therapies in the treatment or prevention of multiple cardiovascular complications.
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Figures

Figure 2.1: RAGE Signaling Increases De Novo Ceramide Biosynthesis In Cardiomyocytes. Cardiac
myocytes (H9C2) were treated for 24 h with either normal growth media (CON) or growth media infused
with carboxy-methyl lysine BSA (CML; 30 μL/ml growth media), with and without myriocin (Myr; 10
μM). Following the treatment period, expression levels of SPT1, SPT2, and CerS2 were quantified
(Figure 2.1A, n=3), in addition to ceramides (Figure 2.1B, n=3). *, p < 0.05 for CML vs. other treatments.
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Figure 2.2: RAGE Signaling Reduces Cardiomyocyte Mitochondrial Respiration Through Ceramide
Accrual. Cardiac myocytes (H9C2, n=3) were treated for 24 h with either normal growth media or growth
media containing CML-BSA with and without myriocin (Con, CML, CML+Myr). Following treatment,
heart cell mitochondrial oxygen consumption was assessed using a substrate-uncoupler-inhibitor titration
protocol (Figure 2.2A; See Figure 2.2C for description). Complex II Control Factor was used to
determine the specific effect on succinate addition on respiration (Figure 2.2B). *, p < 0.05 for CML vs.
other treatments.
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Figure 2.3: Cigarette Smoke Increases RAGE Expression In Heart With Secondhand Cigarette Smoke
Exposure. WT mice were restrained and exposed to either room air (n=3) or secondhand cigarette smoke
(n=3, see materials and methods) for 8 wk. Following the exposure period, western blot (Figure 2.3A) and
quantification (Figure 2.3B) was performed on heart tissue lysates to determine relative expression levels
of RAGE. *, p < 0.05 for smoke vs. restrain.
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Figure 2.4: RAGE KO Prevents Heart Ceramide Accrual With Cigarette Smoke. WT and RAGE KO
mice were restrained and exposed to either room air or acute secondhand cigarette smoke for 1 wk.
Following the exposure period, lipids were isolated from heart tissue and analyzed for ceramides (Figure
2.4A). Immunohistochemical staining for ceramide was also performed to qualitatively depict any
differences in heart tissue between WT and RAGE KO mice under the different exposure conditions
(Figure 2.4B). ceramides were significantly increased in WT mice exposed to tobacco smoke (arrow)
compared to exposed RAGE KO mice. Scale bars represent 200 nm and *, p < 0.05 for smoke vs.
restrain within each group.
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Figure 2.5: RAGE KO Prevents Cigarette Smoke-Induced Reduced Myocardial Mitochondrial
Respiration. WT and RAGE KO mice were restrained and exposed to either room air or acute secondhand
cigarette smoke for one wk. Following the exposure period, mitochondrial oxygen consumption of
cardiac myocytes was assessed (Figure 2.5A). Complex II Control Factor was used to determine the
specific effect on succinate addition on respiration (Figure 2.5B).*, p < 0.05 for smoke vs. other
treatments. #, p < 0.05 for RAGEKO-Smoke vs. RAGEKO-Restrain.
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Figure 2.6: Conditional Up-Regulation of Pulmonary RAGE Expression Increases Heart Ceramides. Nontransgenic controls (Con) and Transgenic (RAGE TG) mice that overexpress RAGE were sacrificed and
assessed for ceramide levels in cardiac tissue. *, p < 0.05 for RAGE TG vs WT.
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CHAPTER 3: General Discussion And Future Directions
Our data from the previous chapter reinforce other studies implicating RAGE and
ceramide in cardiovascular disease. RAGE signaling contributes to cardiomyopathy (Park et al.,
2008), coronary heart disease (Ligthart et al., 2014), atherosclerosis (Johnson et al., 2014), and
even elicits endothelial dysfunction (Wu et al., 2013). This work, however, suggests that cardiac
lipotoxicity and excessive accumulation of ceramides mediate, at least in part, the effects of
RAGE in diabetic- and smoke-induced cardiovascular disease. Our rationale for looking at
RAGE as a mediator of ceramide lipotoxicity stems from work conducted in our lab, as well as
other studies that looked at TLR4. TLR4 mediates lipid- and endotoxin-induced ceramide
biosynthesis and shares many signaling pathways and ligand activators with RAGE (Schilling et
al., 2013).
The first point presented in our research is that advanced glycation end-products reduce
cardiomyocyte mitochondrial function in a ceramide-dependent manner. AGEs, including
proteins with N (ε)-(carboxymethyl) lysine adducts, are important in a number of diabetic- and
smoke-induced pathologies (Schmitt, Linder, Standker, Hammes, & Preissner, 2008) and have
been previously shown to induce oxidative stress (Wang et al., 2014) and impair mitochondrial
function in cardiac myocytes (L. Zhang et al., 2014). Our rationale for exposing cardiac
myocytes to CML-BSA and mice to cigarette smoke stems from evidence that various factors
including diet (Poulsen et al., 2013), cigarette smoke (Cerami et al., 1997), and chronic
hyperglycemia increase serum levels of advanced glycation end-products (Gaens, Stehouwer, &
Schalkwijk, 2013).
The finding that RAGE signaling in lung contributed to cigarette smoke-induced
ceramide accrual in cardiomyocytes is novel and has broad implications for future studies
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looking at the interactions between heart and lung. Our lab previously showed that cigarette
smoke increases cardiomyocyte ceramide accumulation (Tippetts et al., 2014); however, the data
presented here take it one step further by offering a mechanism to account for the increase in
cardiac ceramides. While other factors certainly may contribute to cardiac lipotoxicity (van de
Weijer, Schrauwen-Hinderling, & Schrauwen, 2011), the RAGE-ceramide axis is a novel area of
research that merits further investigation.
Furthermore, our data showed that RAGE signaling was necessary for cigarette smokemediated reductions in myocardial mitochondrial respiration. A robust increase in cardiac
ceramides was observed in wild type mice, but the RAGE KO mice were protected from smokeinduced reduced respiration. Cardiomyocytes, in particular, are dependent on efficient
mitochondrial metabolism (Wohlgemuth, Calvani, & Marzetti, 2014) and healthy turnover by
carefully regulated mitochondrial fission-fusion events. Previous research conducted by Zhu et
al. suggested that AGE-RAGE interactions may interfere with proper mitochondrial dynamics
leading to increased apoptosis (Zhu et al., 2011). Several studies have even reported that
inhibition of mitochondrial fission attenuates the progression of cardiovascular disease (Kubli &
Gustafsson, 2012; Ong et al., 2010). Likewise, ceramides have also been reported to reduce
contractility (Simon et al., 2014) and stimulate apoptosis by stimulating cytochrome-c release
from mitochondria (Parra et al., 2013).
Although the work here suggests a novel function for RAGE, further studies are needed
to clarify signaling pathways that interconnect RAGE and ceramide. Our work demonstrated that
RAGE signaling increased expression of several enzymes involved in ceramide biosynthesis;
however, it’s unclear which signaling pathways RAGE is acting through and whether it also
results in increased activation of the de novo enzymes regulating ceramide synthesis. RAGE and

38

TLR4 both signal through the canonical NF-kβ pathway to increase expression of inflammatory
cytokines (Ibrahim, Armour, Phipps, & Sukkar, 2013; Reynolds, Kasteler, Schmitt, & Hoidal,
2011) but whether the NF-kβ pathway is involved has yet to be determined. Furthermore, it
would be insightful to perform studies evaluating heart and lung interactions in the context of
environmental issues, including inversion, to see whether cardiac myocyte respiration is hindered
in response to exposure to particulate matter in the community.
This research also has broad implications for potential cardiovascular therapies.
Importantly, it suggests that anti-RAGE and anti-ceramide approaches may alleviate
cardiovascular symptoms in individuals with diabetes and chronic cigarette smoke exposure.
Previous studies have shown that RAGE expression is attenuated by pharmacological treatment
with a wide array of drugs including metformin (T. Zhang, Hu, Cai, Yi, & Wen, 2014), calcitriol
(Lee et al., 2014), atorvastatin (Feng et al., 2011), and pioglitazone. Aside from targeting of
RAGE, however, emphasis should also be placed on managing serum AGE levels and finding
effective ways to reduce their interaction with RAGE. Vulesevic et al. recently suggested
pharmacological targeting of methylglyoxal as a means of alleviating cardiovascular disease
(Vulesevic, Milne, & Suuronen, 2014). Fukami et al. also suggested that administration of
soluble RAGE (sRAGE) may reduce levels of inflammation and serve a protective function
(Fukami, Yamagishi, & Okuda, 2014). Regardless of the method, however, a common thread
among many of these authors is that blockade of AGE/RAGE interaction and signal transduction
reduces oxidative stress and attenuates myocardial injury (Daffu et al., 2013).
Finally, there is also the potential for anti-ceramide therapies in the treatment of
cardiovascular disease. Indeed, numerous studies have shown that inhibition of ceramide
synthesis improves vascular function (Q. J. Zhang et al., 2012) and alleviates both
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atherosclerosis (Chun et al., 2011) and cardiomyopathy (Park et al., 2008). Despite the beneficial
effects of ceramide inhibitors such as myriocin and fumonisin B1 in these models of
cardiovascular disease (Park et al., 2008), however, there remains a need to discover a ceramide
blocker that is safe and effective in humans.
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